Trialbee and Evidation Partner to Accelerate and Diversify Clinical Research Recruitment, Harnessing Evidation’s Direct-to-Participant Research Platform and Community of Millions
Visit Evidation and Trialbee at the DPharm conference September 17-18 in Philadelphia to learn how their joint offering and shared commitment to inclusion and data transparency drives enrollment outcomes
Malmo, Sweden and San Francisco, CA — September 17, 2024 – Trialbee, the global leader in technology-driven patient recruitment for clinical trials, is proud to partner with Evidation, the company creating new ways to measure and improve health in everyday life with its suite of direct-to-participant health research solutions. The goal of the collaboration is to connect Evidation’s diverse and active Member community with more and better clinical research opportunities. The companies will kick off this collaboration by supporting recruitment for an otolaryngology trial sponsored by a top 20 pharmaceutical company.
Attendees of the DPharm conference (September 17-18, 2024) in Philadelphia can learn more about Trialbee and Evidation’s joint offering by visiting Trialbee at booth #97 and Evidation at booth #15.
Evidation’s app and research platform makes it possible to connect directly with millions of individuals to conduct real-world health research, outside the clinic—to measure health in everyday life and create a more complete picture of an individual’s health journey. As a trusted source of health data and insights, Evidation is built on its close and long-term relationships with its members, its relevant and personalized content, and its focus on transparency and consent. Evidation’s community is uniquely comprised of almost 5 million individuals across more than 97% of zip codes in the United States. Evidation’s integration with Trialbee’s Honey Platform™ offers trial sponsors the ability to connect with a highly responsive pool of potential participants while utilizing Honeybee’s unprecedented recruitment capabilities.
“Evidation and Trialbee both seek to enable faster, more diverse, and more inclusive clinical trials, and this collaboration serves this joint vision,” said Christine Lemke, Co-founder and CEO of Evidation. “Evidation is one of the largest virtually connected health research cohorts in the United States. Our Member community is deeply characterized—with over 1 million individuals identifying as having a chronic disease. Evidation Members are engaged and motivated to participate in research over the long-term and keep coming back for personalized insights and our system of transparent rewards.”
The partnership offers trial sponsors a powerful platform to connect with patients who are actively engaged and responsive. Interested patients are directed to an informative study page created by Trialbee, pre-qualified by live medical secondary screening, and managed in the Honey Platform. This integrated process provides sponsors with valuable insights into patient pipelines, recruitment progress, and site performance – with integrated tools that improve site-to-patient communication - to enhance the overall trial experience.
“In Evidation, we have a dedicated partner that shares our values including an unwavering promise of equitable access for all patients, and a commitment to transparency mirrored by our Patient Recruitment Platform (PRP) called Honey,” said Maggie Adamski, Vice President of Omnichannel Solutions at Trialbee. “Their diverse and inclusive virtual cohort is energized and engaged, and we are honored to help them offer access to all segments of the population. And maybe what’s best is the way we are together able to ensure that individuals in their community are not only informed but also valued throughout the recruitment process from interest through enrollment.”
Evidation is the latest proven partner to join Trialbee’s curated Omnichannel Network that provides access to engaged patient communities including specific therapeutic areas and geographies. Other partners include Inspire Health, Belong.Life, Savvy Cooperative, Massive Bio, and Evernorth. If your organization is passionate about connecting patients and families to clinical trials, apply to join at omnichannel@trialbee.com.
Learn more about the collaboration by visiting www.evidation.com and www.trialbee.com.
About Trialbee
Trialbee is a leading provider of patient recruitment and retention solutions for clinical trials. With innovative tools and a commitment to improving trial efficiency, Trialbee helps sponsors connect with the right patients at the right time.
About Evidation
Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe. Learn more at www.evidation.com
Media Contact for Trialbee
Kristopher Sarajian
kristopher.sarajian@trialbee.com
Media Contact for Evidation
Amy Puliafito
press@evidation.com